Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CordenPharma Plankstadt announced the design and installment of a new manufacturing line dedicated to producing Veterinary Drug Products for 500kg scale batch sizes to supply a complex product for application in the veterinary health market.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna to create a new generation of transformative medicines for patients.
read more
Wednesday, January 31, 2018
A group of industry investors has announced the acquisition of CorePharma, its facilities and equipment in Middlesex, NJ from Impax Laboratories.
read more
CoreRx, Inc., an industry leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California,
read more
CoreRx, Inc., a CDMO with formulation, development and GMP manufacturing sites in Clearwater, Florida and San Rafael, California, is pleased to announce the appointment of Sitakant (S.K.) Chaudhury as Chief Financial Officer and as a member of CoreRx...
read more
CoreRx, Inc. announced the appointment of Dan Dobry as Chief Strategy Officer and a member of CoreRx’s Executive Leadership Team. Dan will report to CoreRx’s Chief Executive Officer, Ajay Damani.
read more
CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces Michael Grass, Ph.D. has joined CoreRx as Senior Director of Product ...
read more
Wednesday, September 25, 2013
CoreRx, a leader in early pharmaceutical development services, recently announced the addition of Dr. Janice Cacace, who will serve as Director, Formulation Development
read more
Continuing to exceed industry expectations, CoreRx, a Tampa-based pharmaceutical development company, added two new critical roles to their growing organization; Director of Commercial Manufacturing, and a Manager of Marketing & Strategic Development...
read more
Clearwater, Florida -- CoreRx, Inc. today announced plans for an approximately $2 million expansion of its manufacturing capabilities in Clearwater, Florida. The expansion will introduce a new facility for hormone development, clinical trial ...
read more
Coriolis Pharma, a globally operating service provider in formulation research and development of biopharmaceutical drugs, announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2).
read more
After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development. Formulation development for ATMPs, including cell culture ...
read more
Wednesday, October 16, 2019
CorMedix has completed its interaction with the FDA related to the CMC package that will be needed to support Neutrolin’s NDA.
read more
Corning announced an investment in Corning Valor Glass to build a high-volume manufacturing facility that will create over 300 new jobs in Durham County, North Carolina.
read more
The Medical CBRN Defense Consortium has released a RFI seeking solutions to combat the novel Coronavirus pandemic.
read more